s6y
Company name or ticker
Search
Ernexa Therapeutics Inc.
ARS
Annual report to security holders
Filed
Wednesday, October 16, 2024
Period
Dec 31, 2023
Accession number
0001493152-24-041302
Documents
formars.pdf
ARS
On sec.gov
Filing index
All files
Complete submission text
SGML header